National Comprehensive Cancer Network (NCCN) on Medscape
JNCCN (Journal of the National Comprehensive Cancer Network)
- Beyond the Guidelines in the Treatment of Peripheral T-cell Lymphoma: New Drug Development
- Neoadjuvant Chemotherapy in Stage III NSCLC
- Infectious Complications Associated With Immunomodulating Monoclonal Antibodies Used in the Treatment of Hematologic Malignancy
- PET in Cervical Cancer -- Implications for 'Staging,' Treatment Planning, Assessment of Prognosis, and Prediction of Response
- Early Detection and Biomarkers in Pancreatic Cancer
News from NCCN 13th Annual Conference, March 5-9, 2008
- New Colon and Rectal Cancer Guidelines Chart Chemotherapy Options
- New Guidelines Offer Distinct Algorithm for Inflammatory Breast Cancer
- New Prostate Cancer Guidelines Add Intensity-Modulated Radiotherapy
- New Chronic Myelogenous Leukemia Guidelines Add Nilotinib
With Video - Video Highlights From the National Comprehensive Cancer Network (NCCN) 13th Annual Conference
With Video - New Lung Cancer Guidelines Advise Adjuvant Therapy in Early Disease
- Doctors Weigh Risks and Benefits of Imaging in Cancer Patients
- Experts Assess How the Internet Is Changing Doctor-Patient Interactions
CME Activities
- NCCN Task Force Report: Breast Cancer in the Older Woman
- NCCN Task Force Report: Prevention and Management of Mucositis in Cancer Care
- NCCN Task Force Report: PET/CT Imaging
- NCCN Clinical Practice Guidelines in Oncology: Kidney Cancer
- NCCN Clinical Practice Guidelines in Oncology Symposium: Colon, Rectal, & Anal Cancers
- NCCN Clinical Practice Guidelines in Oncology Symposium: Breast Cancer
- NCCN Clinical Practice Guidelines in Oncology Symposium: Kidney Cancer
- NCCN Clinical Practice Guidelines in Oncology Symposium: Non-Small Cell Lung Cancer
- NCCN 2nd Annual Congress: Hematologic Malignancies - Blood Products and Growth Factors in the Treatment of Thrombocytopenia
- NCCN 2nd Annual Congress: Hematologic Malignancies - Transfusion Support and Iron Overload in Myelodysplastic Syndromes
- NCCN 2nd Annual Congress: Hematologic Malignancies - Update on Primary Therapy, Second-Line Therapy, and New Agents for Chronic Myelogenous Leukemia
- NCCN Task Force Report: Gastrointestinal Stromal Tumors (GISTs)
- Advances in the Treatment of Chronic Myelogenous Leukemia
- Management of Tumor Lysis Syndrome
- NCCN Non-Small Cell Lung Cancer Guidelines Update
- NCCN Breast Cancer Guidelines Update
NCCN Clinical Practice Guidelines in Oncology™
- National Comprehensive Cancer Network (NCCN) Colon Cancer and Rectal Cancer Guidelines, Version 1.2008
- National Comprehensive Cancer Network (NCCN) Non-Small Cell Lung Cancer Guideline, Version 2.2008
- National Comprehensive Cancer Network (NCCN) Breast Cancer Guideline, Version 2.2008
- National Comprehensive Cancer Network (NCCN) Prostate Cancer Guideline, Version 1.2008
About NCCN
The National Comprehensive Cancer Network (NCCN), a not-for-profit alliance of 21 of the world's leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the health care delivery system. As the arbiter of high-quality cancer care, NCCN promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients, clinicians, and other health care decision-makers. The primary goal of all NCCN initiatives is to improve the quality, effectiveness, and efficiency of oncology practice so patients can live better lives.
NCCN Member Institutions
- City of Hope, Los Angeles, CA
- Dana-Farber/Brigham and Women's Cancer Center | Massachusetts General Hospital Cancer Center, Boston, MA
- Duke Comprehensive Cancer Center, Durham, NC
- Fox Chase Cancer Center, Philadelphia, PA
- Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT
- Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, Seattle, WA
- Arthur G. James Cancer Hospital & Richard J. Solove Research Institute at The Ohio State University, Columbus, OH
- The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD
- Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL
- Memorial Sloan-Kettering Cancer Center, New York, NY
- H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
- Roswell Park Cancer Institute, Buffalo, NY
- Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, St. Louis, MO
- St. Jude Children's Research Hospital/University of Tennessee Cancer Institute, Memphis, TN
- Stanford Comprehensive Cancer Center, Stanford, CA
- University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA
- University of Michigan Comprehensive Cancer Center, Ann Arbor, MI
- UNMC Eppley Cancer Center at The Nebraska Medical Center, Omaha, NE
- The University of Texas M. D. Anderson Cancer Center, Houston, TX
- Vanderbilt-Ingram Cancer Center, Nashville, TN
